Evaxion A/S (EVAX)
About Evaxion A/S (EVAX)
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
- 46
- 2021
- XNAS
90-Day SEC Filing Activity
No Form 4 activity for EVAX in the last 90 days.
EVAX Insider Transactions (Form 4)
0No Form 4 filings for EVAX yet.
Transactions appear here automatically as insiders file with the SEC.
EVAX Insider Trading - FAQ
Where can I see EVAX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks EVAX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow EVAX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add EVAX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where EVAX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track EVAX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
